Skip to main content

Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.

Publication ,  Journal Article
Lew, MV; Ren, Y; Lowder, YP; Siamakpour-Reihani, S; Ramalingam, S; Romero, KM; Thompson, JC; Bohannon, LM; McIntyre, J; Tang, H; Van Opstal, J ...
Published in: Transplant Cell Ther
August 2022

Allogeneic hematopoietic stem cell transplantation (HCT) is a potentially curative treatment for both malignant and nonmalignant hematologic diseases; however, reported rates of treatment-related mortality approach 30%. Outcomes are worse in patients who begin HCT with functional impairments. To detect such impairments, a geriatric assessment (GA) is recommended in adults age ≥65 years. Younger HCT candidates also may be impaired because of chemotherapy regimens pre-HCT. Therefore, we hypothesized that GA can be beneficial for adult patients of all ages and subsequently created a clinical pretransplantation optimization program to assess all HCT candidates using a modified GA. One-hundred fifty-seven patients were evaluated in 4 functional domains- physical, cognitive, nutritional, and psychological-at 2 time points prior to HCT-new patient evaluation (NPE) and sign-off (SO)-between October 2017 and January 2020. At NPE, 80.9% of the patients had at least 1 domain with a functional impairment, and physical (P = .006), cognitive (P = .04), and psychological (P = .04) impairments were associated with an increased likelihood of not proceeding to HCT. In addition, patients age 18 to 39 years were more likely than older patients to have a physical function impairment (P = .001). Between NPE and SO, 51.9% of the patients had resolution of 1 or more impairments, and nutritional impairment at SO was predictive of worse overall survival (P = .01). Our study shows that GA can identify functional impairments in patients of all ages. Early identification of impairments could facilitate referrals to supportive care and resolution of impairments prior to HCT, suggesting that GA could be recommended for HCT candidates of all ages.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Transplant Cell Ther

DOI

EISSN

2666-6367

Publication Date

August 2022

Volume

28

Issue

8

Start / End Page

498.e1 / 498.e9

Location

United States

Related Subject Headings

  • Young Adult
  • Transplantation, Homologous
  • Transplantation Conditioning
  • Risk Assessment
  • Middle Aged
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Geriatric Assessment
  • Aged, 80 and over
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lew, M. V., Ren, Y., Lowder, Y. P., Siamakpour-Reihani, S., Ramalingam, S., Romero, K. M., … Sung, A. D. (2022). Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years. Transplant Cell Ther, 28(8), 498.e1-498.e9. https://doi.org/10.1016/j.jtct.2022.05.018
Lew, Meagan V., Yi Ren, Yen P. Lowder, Sharareh Siamakpour-Reihani, Sendhilnathan Ramalingam, Kristi M. Romero, Jillian C. Thompson, et al. “Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.Transplant Cell Ther 28, no. 8 (August 2022): 498.e1-498.e9. https://doi.org/10.1016/j.jtct.2022.05.018.
Lew MV, Ren Y, Lowder YP, Siamakpour-Reihani S, Ramalingam S, Romero KM, et al. Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years. Transplant Cell Ther. 2022 Aug;28(8):498.e1-498.e9.
Lew, Meagan V., et al. “Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.Transplant Cell Ther, vol. 28, no. 8, Aug. 2022, pp. 498.e1-498.e9. Pubmed, doi:10.1016/j.jtct.2022.05.018.
Lew MV, Ren Y, Lowder YP, Siamakpour-Reihani S, Ramalingam S, Romero KM, Thompson JC, Bohannon LM, McIntyre J, Tang H, Van Opstal J, Johnson E, Cohen HJ, Bartlett DB, Pastva AM, Morey M, Hall KS, Smith P, Peters KB, Somers TJ, Kelleher S, Smith SK, Wischmeyer PE, Lin P-H, Wood WA, Thorpe G, Minor K, Wiggins K, Hennig T, Helms T, Welch R, Matthews B, Liu J, Burleson J, Aberant T, Engemann AK, Henshall B, Darby M, Proch C, Dellascio M, Pittman A, Suminguit J, Choi T, Gasparetto C, Long GD, Lopez RD, Sarantopoulos S, Horwitz ME, Chao NJ, Sung AD. Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years. Transplant Cell Ther. 2022 Aug;28(8):498.e1-498.e9.

Published In

Transplant Cell Ther

DOI

EISSN

2666-6367

Publication Date

August 2022

Volume

28

Issue

8

Start / End Page

498.e1 / 498.e9

Location

United States

Related Subject Headings

  • Young Adult
  • Transplantation, Homologous
  • Transplantation Conditioning
  • Risk Assessment
  • Middle Aged
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Geriatric Assessment
  • Aged, 80 and over